| Filed On | Filing |
|---|---|
| 06 Jul 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation
1 Private & Confidential July 2026 Albert Manzone Dear Albert, Perrigo Pharma International D.A.C (Perrigo) is pleased to offer you the position of Interim President and Chief Executive Officer. Our employment offer is subject to the ter... |
| 06 Nov 2024 |
8-K/A: Results of Operations and Financial Condition
Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion |
| 15 Jul 2022 |
8-K/A: Completion of Acquisition or Disposition of Assets
We have audited the consolidated financial statements of HERA S.A.S. and its subsidiaries (the Company), which comprise the consolidated statement of financial position as of December 31, 2021, and the related consolidated statements of ... |
| 21 Jul 2017 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 30 May 2017 | 8-K/A: Financial Statements and Exhibits |
| 15 Jun 2015 | 8-K/A: Financial Statements and Exhibits |
| 18 Feb 2014 | 8-K/A: Financial Statements and Exhibits |
Loading...
